Participant flow12

How many started, completed or left each group, period by period.

1 to 12 of 12

Period	Milestone	Group	Participants
Overall Study	STARTED	GSP 301 NS	302
Overall Study	STARTED	Olopatadine HCl NS	297
Overall Study	STARTED	Mometasone Furoate NS	294
Overall Study	STARTED	GSP 301 Placebo NS	287
Overall Study	COMPLETED	GSP 301 NS	289
Overall Study	COMPLETED	Olopatadine HCl NS	278
Overall Study	COMPLETED	Mometasone Furoate NS	283
Overall Study	COMPLETED	GSP 301 Placebo NS	276
Overall Study	NOT COMPLETED	GSP 301 NS	13
Overall Study	NOT COMPLETED	Olopatadine HCl NS	19
Overall Study	NOT COMPLETED	Mometasone Furoate NS	11
Overall Study	NOT COMPLETED	GSP 301 Placebo NS	11

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT02631551/flow